|
Video: What is a Stock Split?
|
|
Rexahn Pharmaceuticals is a biopharmaceutical company engaged in the discovery, development and commercialization of treatments for cancer. Co.'s clinical pipeline features two oncology product candidates in clinical development and additional compounds in pre-clinical development. Co.'s drug candidates are: RX-3117, which is an oral, small molecule nucleoside compound that provides the potential for a targeted anti-cancer therapy; and RX-5902 (Supinoxin), which is a small molecule inhibitor of phosphorylated-p68 that selectively blocks the interaction of phosphorylated p68 with beta-catenin, thereby decreasing the proliferation or growth of cancer cells in preclinical models. According to our RNN split history records, RNN has had 2 splits. | |
|
RNN (RNN) has 2 splits in our RNN split history database. The first split for RNN took place on May 05, 2017. This was a 1 for 10 reverse split, meaning for each 10 shares of RNN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split. RNN's second split took place on April 12, 2019. This was a 1 for 12 reverse split, meaning for each 12 shares of RNN owned pre-split, the shareholder now owned 1 share. For example, a 100 share position pre-split, became a 8.33333333333333 share position following the split.
When a company such as RNN conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the RNN split history from start to finish, an original position size of 1000 shares would have turned into 8.33333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into RNN shares, starting with a $10,000 purchase of RNN, presented on a split-history-adjusted basis factoring in the complete RNN split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/09/2014 |
|
End date: |
06/07/2019 |
|
Start price/share: |
$90.00 |
|
End price/share: |
$5.24 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-94.18% |
|
Average Annual Total Return: |
-45.65% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$582.41 |
|
Years: |
4.66 |
|
|
|
Date |
Ratio |
05/05/2017 | 1 for 10 | 04/12/2019 | 1 for 12 |
|
|